Feitong Bio
Chengdu
About Feitong Bio
Feitong Bio platform discovers and develops innovative drugs using monoclonal antibody screening, molecular activity detection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $15.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: soundbiopharma.com
- Phone: +86 28-61313120
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/feitong-bio-140956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.